ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,528Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 439

$612K Total Retail Price of All Prescriptions

Rank: 49 out of 439

837 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 837 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 13,266 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
CARVEDILOL 914 784 1 8
SIMVASTATIN 828 717 2 3
FUROSEMIDE 818 682 3 5
CLOPIDOGREL 750 652 4 16
AMLODIPINE BESYLATE 656 600 5 2
LISINOPRIL 559 490 6 4
PLAVIX 513 461 7 26
ISOSORBIDE MONONITRATE ER 431 382 8 28
METOPROLOL SUCCINATE 410 365 9 13
DIGOXIN 385 309 10 38
SOTALOL 383 340 11 168
ATENOLOL 374 293 12 24
NITROSTAT 371 281 13 70
WARFARIN SODIUM 320 261 14 10
LOSARTAN POTASSIUM 312 262 15 31
METOPROLOL TARTRATE 291 268 16 11
OMEPRAZOLE 289 264 17 6
HYDROCODONE-ACETAMINOPHEN 280 180 S3 18 1
TRIAMTERENE-HCTZ 273 239 19 112
POTASSIUM CHLORIDE 258 238 20 30
SPIRONOLACTONE 252 191 21 104
PRAVASTATIN SODIUM 220 213 22 23
TRAMADOL HCL 208 166 23 21
CLONIDINE HCL 175 156 24 47
ATORVASTATIN CALCIUM 162 157 25 12
LEVOTHYROXINE SODIUM 135 131 26 9
VERAPAMIL ER 132 116 27 128
PANTOPRAZOLE SODIUM 131 107 28 60
KLOR-CON M20 120 94 29 77
KLOR-CON 10 115 98 30 179
HYDROCHLOROTHIAZIDE 115 107 30 18
ALLOPURINOL 113 101 32 54
RANITIDINE HCL 102 74 33 39
SERTRALINE HCL 101 97 34 44
DIOVAN 98 98 35 65
PINDOLOL 93 93 36 353
GABAPENTIN 90 83 37 7
TERAZOSIN HCL 89 66 38 183
ZOLPIDEM TARTRATE 89 82 38 14
LOVASTATIN 82 82 40 103
NEXIUM 81 77 41 32
RANEXA 77 63 42 166
ALPRAZOLAM 74 59 43 216
CARISOPRODOL 72 52 R 44 19
AMIODARONE HCL 70 58 45 94
FLUDROCORTISONE ACETATE 66 65 46 385
NIFEDIPINE ER 65 64 47 83
NITROGLYCERIN PATCH 65 55 47 132
ZETIA 63 53 49 99
PROPAFENONE HCL 62 55 50 206
METOLAZONE 61 46 51 208
TRAZODONE HCL 60 58 52 35
RAMIPRIL 58 58 53 118
SUCRALFATE 52 51 54 152
DILTIAZEM HCL 51 35 55 333
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.